PROFOUND MEDICAL CORP. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
PROFOUND MEDICAL CORP. (PROF) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 121.60 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-06
- PROFOUND MEDICAL CORP. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 49.60K shares, a 5.76% increase year-over-year.
- PROFOUND MEDICAL CORP. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 72.00K shares, a 900.00% increase year-over-year.
- PROFOUND MEDICAL CORP. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 0.00 shares.
- PROFOUND MEDICAL CORP. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 38.80K shares.
- PROFOUND MEDICAL CORP. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 92.90K shares, a 90.19% decline from fiscal 2024.
- PROFOUND MEDICAL CORP. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 946.90K shares, a 1496.80% increase from fiscal 2023.
- PROFOUND MEDICAL CORP. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 59.30K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 49.60K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 121.60K shares 10-Q · filed 2026-08-06 | 121.60K shares derived: sum of 3 quarters · filed 2026-08-06 | 160.40K shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 72.00K shares 10-Q · filed 2026-05-07 | 72.00K shares derived: sum of 2 quarters · filed 2026-05-07 | 110.80K shares derived: sum of 3 quarters · filed 2026-05-07 | 157.70K shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | 38.80K shares derived: sum of 2 quarters · filed 2026-03-05 | 85.70K shares derived: sum of 3 quarters · filed 2026-03-05 | 92.90K shares 10-K · filed 2026-03-05 |
| 2025-09-30 | 38.80K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | 85.70K shares derived: sum of 2 quarters · filed 2025-11-13 | 92.90K shares 10-Q · filed 2025-11-13 | |
| 2025-06-30 | 46.90K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | 54.10K shares 10-Q · filed 2025-08-14 | ||
| 2025-03-31 | 7.20K shares 10-Q · filed 2025-05-08 | |||
| 2024-12-31 | 946.90K shares 10-K · filed 2026-03-05 | |||
| 2023-12-31 | 59.30K shares 10-K · filed 2025-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |